TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Orion Corporation
Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

BlackRock, Inc. has reduced its ownership stake in Orion Corporation below the 5% disclosure threshold as of January 8, 2026. Separately, Orion Pharma announced the initiation of the TEADES Phase 2 clinical trial for ODM-212 in treating Malignant Pleural Mesothelioma and Epithelioid Hemangioendothelioma.

Insights
BLK   neutral

The reduction of stake below 5% is a routine portfolio adjustment and does not indicate positive or negative sentiment toward Orion. It is a factual disclosure of ownership change without inherent positive or negative implications.